Status:
COMPLETED
Post-ICU Follow-up Study in Covid-19 Patients
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
COVID-19 Pandemic
Intensive Care Unit Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
A follow up study of adult patients who have been treated in the ICU at Mölndal hospital due to Covid19 in the period of 2020 to 2022.
Detailed Description
The spread of Covid19 in the population in Sweden from 2019 and onwards posed new and serious strain on our ICU capacity. The disease presented with initially influenza like symptoms and evolved into ...
Eligibility Criteria
Inclusion
- Patients treated at the Intensive Care Unit at Mölndals hospital from 2020 to 2022 for Covid19
- More than 3 months passed since ICU discharge
- Over 18 years of age at time of inclusion
- Swedish resident with Swedish unique personal identification number.
- Informed consent
Exclusion
- Under 18 years of age at time of inclusion
- Not a Swedish resident
- Unwillingness to participate
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
793 Patients enrolled
Trial Details
Trial ID
NCT05299346
Start Date
October 1 2020
End Date
September 1 2023
Last Update
May 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sahlgrenska University Hospital
Mölndal, Västra Götaland County, Sweden, 431 80